Volume 30, Issue 1
Research Article

Several methods to assess improvement in risk prediction models: Extension to survival analysis

Lloyd E. Chambless

Corresponding Author

E-mail address: wchambless@unc.edu

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, U.S.A.

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, U.S.A.Search for more papers by this author
Christopher P. Cummiskey

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, U.S.A.

Search for more papers by this author
Gang Cui

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27514, U.S.A.

Search for more papers by this author
First published: 08 September 2010
Citations: 112

Abstract

Risk prediction models have been widely applied for the prediction of long‐term incidence of disease. Several parameters have been identified and estimators developed to quantify the predictive ability of models and to compare new models with traditional models. These estimators have not generally accounted for censoring in the survival data normally available for fitting the models. This paper remedies that problem. The primary parameters considered are net reclassification improvement (NRI) and integrated discrimination improvement (IDI). We have previously similarly considered a primary measure of concordance, area under the ROC curve (AUC), also called the c‐statistic. We also include here consideration of population attributable risk (PAR) and ratio of predicted risk in the top quintile of risk to that in the bottom quintile. We evaluated estimators of these various parameters both with simulation studies and also as applied to a prospective study of coronary heart disease (CHD). Our simulation studies showed that in general our estimators had little bias, and less bias and smaller variances than the traditional estimators. We have applied our methods to assessing improvement in risk prediction for each traditional CHD risk factor compared to a model without that factor. These traditional risk factors are considered valuable, yet when adding any of them to a risk prediction model that has omitted the one factor, the improvement is generally small for any of the parameters. This experience should prepare us to not expect large values of the risk prediction improvement evaluation parameters for any new risk factor to be discovered. Copyright © 2010 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 112

  • A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database, BMC Cancer, 10.1186/s12885-020-07019-5, 20, 1, (2020).
  • Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes, Diabetes Care, 10.2337/dc19-2043, 43, 6, (1200-1208), (2020).
  • Predicting conversion to Alzheimer's disease among individual high‐risk patients using the Characterizing AD Risk Events index model, CNS Neuroscience & Therapeutics, 10.1111/cns.13371, 26, 7, (720-729), (2020).
  • Establishment and Validation of a Nomogram for Tonsil Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database, Cancer Control, 10.1177/1073274820960481, 27, 1, (107327482096048), (2020).
  • Levels and Change in Galectin‐3 and Association With Cardiovascular Events: The ARIC Study, Journal of the American Heart Association, 10.1161/JAHA.119.015405, 9, 13, (2020).
  • Long‐term predictive value of stroke volume index obtained from right heart catheterization: Insights from the veterans affairs clinical assessment, reporting, and tracking program, Clinical Cardiology, 10.1002/clc.23418, 43, 10, (1126-1132), (2020).
  • Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus, Diabetic Medicine, 10.1111/dme.14280, 37, 11, (1910-1918), (2020).
  • Troponin T and N-Terminal Pro–B-Type Natriuretic Peptide: A Biomarker Approach to Predict Heart Failure Risk—The Atherosclerosis Risk in Communities Study, Clinical Chemistry, 10.1373/clinchem.2013.203638, 59, 12, (1802-1810), (2020).
  • Soluble ST2 Is Associated with All-Cause and Cardiovascular Mortality in a Population-Based Cohort: The Dallas Heart Study, Clinical Chemistry, 10.1373/clinchem.2012.191106, 59, 3, (536-546), (2020).
  • Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study, Clinical Chemistry, 10.1373/clinchem.2011.171926, 58, 1, (172-182), (2020).
  • Clinical Utility of Lipoprotein-Associated Phospholipase A2 for Cardiovascular Disease Prediction in a Multiethnic Cohort of Women, Clinical Chemistry, 10.1373/clinchem.2012.188870, 58, 9, (1352-1363), (2020).
  • Revised 15-item MDS-specific frailty scale maintains prognostic potential, Leukemia, 10.1038/s41375-020-01026-y, (2020).
  • Short-term blood pressure variability outweighs average 24-h blood pressure in the prediction of cardiovascular events in hypertension of the young, Journal of Hypertension, 10.1097/HJH.0000000000002074, 37, 7, (1419-1426), (2019).
  • Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study, The Journal of Clinical Hypertension, 10.1111/jch.13584, 21, 7, (966-974), (2019).
  • Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models, Statistics in Medicine, 10.1002/sim.8204, 38, 20, (3817-3831), (2019).
  • GFR-specific cut-offs can refine the prognostic value of circulating cardiac biomarkers in advanced chronic kidney disease, Canadian Journal of Cardiology, 10.1016/j.cjca.2019.06.014, (2019).
  • Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging, Journal of Thoracic Oncology, 10.1016/j.jtho.2019.03.015, (2019).
  • An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring, Leukemia, 10.1038/s41375-019-0666-7, (2019).
  • High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study, Circulation, 10.1161/CIRCULATIONAHA.118.038772, (2019).
  • Lipoprotein(a) and Cardiovascular Risk Prediction Among Women, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.04.060, 72, 3, (287-296), (2018).
  • Cardiovascular disease prevention at the workplace: assessing the prognostic value of lifestyle risk factors and job-related conditions, International Journal of Public Health, 10.1007/s00038-018-1118-2, 63, 6, (723-732), (2018).
  • Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model, Cancer Research and Treatment, 10.4143/crt.2017.033, 50, 1, (103-110), (2018).
  • Practical risk score for 5‐, 10‐, and 20‐year prediction of dementia in elderly persons: Framingham Heart Study, Alzheimer's & Dementia, 10.1016/j.jalz.2017.04.013, 14, 1, (35-42), (2017).
  • Multimodality Strategy for Cardiovascular Risk Assessment, Circulation, 10.1161/CIRCULATIONAHA.117.027272, 135, 22, (2119-2132), (2017).
  • Combined use of short-term and long-term cardiovascular risk scores in primary prevention, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000000509, 18, 5, (318-324), (2017).
  • Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study, Journal of the American Heart Association, 10.1161/JAHA.116.005231, 6, 5, (2017).
  • Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC), Journal of the American Heart Association, 10.1161/JAHA.117.005967, 6, 9, (2017).
  • Ultra-sensitive troponin I is an independent predictor of incident coronary heart disease in the general population, European Journal of Epidemiology, 10.1007/s10654-017-0266-7, 32, 7, (583-591), (2017).
  • Graphics and statistics for cardiology: clinical prediction rules, Heart, 10.1136/heartjnl-2016-310210, 103, 7, (538-545), (2017).
  • Prognostic value of routine laboratory variables in prediction of breast cancer recurrence, Scientific Reports, 10.1038/s41598-017-08240-2, 7, 1, (2017).
  • Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study, The Lancet Infectious Diseases, 10.1016/S1473-3099(17)30117-2, 17, 6, (661-670), (2017).
  • Prognostic value of atherosclerotic burden and coronary vascular function in patients with suspected coronary artery disease, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-017-3800-7, 44, 13, (2290-2298), (2017).
  • Progress of statistical analysis in biomedical research through the historical review of the development of the Framingham score, Irish Journal of Medical Science (1971 -), 10.1007/s11845-017-1718-5, (2017).
  • A risk‐based measure of time‐varying prognostic discrimination for survival models, Biometrics, 10.1111/biom.12628, 73, 3, (725-734), (2016).
  • Discrimination slope and integrated discrimination improvement – properties, relationships and impact of calibration, Statistics in Medicine, 10.1002/sim.7139, 36, 28, (4482-4490), (2016).
  • Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study, European Journal of Preventive Cardiology, 10.1177/2047487316672004, 24, 2, (161-167), (2016).
  • Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study, European Journal of Preventive Cardiology, 10.1177/2047487316638201, 23, 14, (1546-1556), (2016).
  • Cardiovascular Risk Factors and Ischemic Heart Disease, Circulation: Cardiovascular Genetics, 10.1161/CIRCGENETICS.115.001255, 9, 3, (279-286), (2016).
  • Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study, American Journal of Kidney Diseases, 10.1053/j.ajkd.2016.01.015, 68, 1, (68-76), (2016).
  • How many longitudinal covariate measurements are needed for risk prediction?, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2015.06.022, 69, (114-124), (2016).
  • Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study, British Journal of Haematology, 10.1111/bjh.14033, 174, 1, (88-101), (2016).
  • Statistical controversies in clinical research: the importance of importance, Annals of Oncology, 10.1093/annonc/mdw159, 27, 7, (1185-1189), (2016).
  • Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events, Coronary Artery Disease, 10.1097/MCA.0000000000000347, 27, 3, (213-220), (2016).
  • The MEST score provides earlier risk prediction in lgA nephropathy, Kidney International, 10.1038/ki.2015.322, 89, 1, (167-175), (2016).
  • Survival Regression Modeling Strategies in CVD Prediction, International Journal of Endocrinology and Metabolism, 10.5812/ijem.32156, 14, 2, (2016).
  • Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model, Statistical Methods in Medical Research, 10.1177/0962280214567141, 26, 3, (1053-1077), (2015).
  • Prediction of coronary artery disease risk based on multiple longitudinal biomarkers, Statistics in Medicine, 10.1002/sim.6754, 35, 8, (1299-1314), (2015).
  • Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes, Diabetes Care, 10.2337/dc15-0925, 38, 10, (1891-1897), (2015).
  • High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study, American Heart Journal, 10.1016/j.ahj.2014.10.005, 169, 1, (31-38.e3), (2015).
  • Association of computed tomography-derived left ventricular size with major cardiovascular events in the general population: The Heinz Nixdorf recall study, Atherosclerosis, 10.1016/j.atherosclerosis.2015.02.050, 240, 1, (46-52), (2015).
  • NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: The Heinz Nixdorf Recall Study, International Journal of Cardiology, 10.1016/j.ijcard.2015.01.082, 183, (155-161), (2015).
  • Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis, Kidney International, 10.1038/ki.2015.241, 88, 6, (1392-1401), (2015).
  • Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI, Journal of the American Society of Nephrology, 10.1681/ASN.2014060556, 26, 7, (1747-1754), (2014).
  • Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: The CAMUNI–MATISS Cohorts Collaboration Study, European Journal of Preventive Cardiology, 10.1177/2047487314563709, 22, 12, (1618-1625), (2014).
  • Estimation of C-Index for Cox Proportional Hazards Model with Censored Biomarker Covariate Subject to Limits of Detection, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2014.920859, 25, 3, (459-473), (2014).
  • Is pathology necessary to predict mortality among men with prostate-cancer?, BMC Medical Informatics and Decision Making, 10.1186/s12911-014-0114-6, 14, 1, (2014).
  • Added Predictive Value of Night-Time Blood Pressure Variability for Cardiovascular Events and Mortality, Hypertension, 10.1161/HYPERTENSIONAHA.114.03694, 64, 3, (487-493), (2014).
  • Improving long-term prediction of first cardiovascular event: The contribution of family history of coronary heart disease and social status, Preventive Medicine, 10.1016/j.ypmed.2014.04.007, 64, (75-80), (2014).
  • B-Type Natriuretic Peptides Improve Cardiovascular Disease Risk Prediction in a Cohort of Women, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.04.089, 64, 17, (1789-1797), (2014).
  • The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation, Chest, 10.1378/chest.13-1740, 145, 3, (559-566), (2014).
  • Risk score to predict mortality in continuous ambulatory peritoneal dialysis patients, European Journal of Clinical Investigation, 10.1111/eci.12344, 44, 11, (1095-1103), (2014).
  • Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer, Journal of Clinical Oncology, 10.1200/JCO.2013.51.7417, 32, 11, (1136-1142), (2014).
  • Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study, Atherosclerosis, 10.1016/j.atherosclerosis.2014.06.029, 236, 1, (175-181), (2014).
  • The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component, Heart, 10.1136/heartjnl-2013-304664, 100, 15, (1179-1187), (2014).
  • Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts, BMJ Open, 10.1136/bmjopen-2014-004837, 4, 6, (e004837-e004837), (2014).
  • Prognostic ROC Curves, Epidemiology, 10.1097/EDE.0000000000000004, 25, 1, (103-109), (2014).
  • Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI‐HF trial, European Journal of Heart Failure, 10.1093/eurjhf/hfs126, 14, 12, (1410-1419), (2014).
  • Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study, European Journal of Preventive Cardiology, 10.1177/2047487313490256, 21, 9, (1171-1179), (2013).
  • Midlife risk score for the prediction of dementia four decades later, Alzheimer's & Dementia, 10.1016/j.jalz.2013.05.1772, 10, 5, (562-570), (2013).
  • The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes, Diabetes Care, 10.2337/dc13-1165, 37, 1, (295-303), (2013).
  • Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study, Diabetes, 10.2337/db12-1625, 63, 3, (1115-1123), (2013).
  • Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study, European Heart Journal, 10.1093/eurheartj/eht481, 35, 31, (2115-2122), (2013).
  • High-dimensional, massive sample-size Cox proportional hazards regression for survival analysis, Biostatistics, 10.1093/biostatistics/kxt043, 15, 2, (207-221), (2013).
  • Troponin T, N-Terminal Pro–B-Type Natriuretic Peptide, and Incidence of Stroke, Stroke, 10.1161/STROKEAHA.111.000173, 44, 4, (961-967), (2013).
  • Development of a Point-based Prediction Model for the Incidence of Total Stroke, Stroke, 10.1161/STROKEAHA.111.677534, 44, 5, (1295-1302), (2013).
  • Anaemia to predict outcome in patients with acute coronary syndromes, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2013.04.004, 106, 6-7, (357-365), (2013).
  • Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study, The Lancet Diabetes & Endocrinology, 10.1016/S2213-8587(13)70048-2, 1, 3, (183-190), (2013).
  • Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia, Blood, 10.1182/blood-2012-12-471680, 121, 21, (4287-4294), (2013).
  • Development and Validation of a Cardiovascular Risk Assessment Model in Patients With Established Coronary Artery Disease, The American Journal of Cardiology, 10.1016/j.amjcard.2013.02.049, 112, 1, (27-33), (2013).
  • Novel genetic markers improve measures of atrial fibrillation risk prediction, European Heart Journal, 10.1093/eurheartj/eht033, 34, 29, (2243-2251), (2013).
  • Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study, The Lancet Oncology, 10.1016/S1470-2045(12)70517-X, 14, 1, (81-87), (2013).
  • Large‐scale parametric survival analysis, Statistics in Medicine, 10.1002/sim.5817, 32, 23, (3955-3971), (2013).
  • Inflammation and the Metabolic Syndrome: Clustering and Impact on Survival in a Swedish Community-Based Cohort of 75 Year Olds, Metabolic Syndrome and Related Disorders, 10.1089/met.2012.0100, 11, 2, (92-101), (2013).
  • Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population, Journal of the American College of Cardiology, 10.1016/j.jacc.2012.11.062, 61, 13, (1388-1395), (2013).
  • Assessing risk in chronic kidney disease: a methodological review, Nature Reviews Nephrology, 10.1038/nrneph.2012.248, 9, 1, (18-25), (2012).
  • Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models, Statistics in Medicine, 10.1002/sim.5598, 32, 4, (661-672), (2012).
  • A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups, Medical Decision Making, 10.1177/0272989X12461856, 33, 2, (154-162), (2012).
  • A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data, Statistics in Medicine, 10.1002/sim.5647, 32, 14, (2430-2442), (2012).
  • Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories, European Journal of Epidemiology, 10.1007/s10654-012-9744-0, 28, 1, (25-33), (2012).
  • Incremental value in outcome prediction with gene expression-based signatures in diffuse large B-cell lymphoma, Blood, 10.1182/blood-2012-08-450106, 121, 1, (156-158), (2012).
  • A method for the early health technology assessment of novel biomarker measurement in primary prevention programs, Statistics in Medicine, 10.1002/sim.5434, 31, 23, (2733-2744), (2012).
  • Added Predictive Ability of the CHA 2 DS 2 VASc Risk Score for Stroke and Death in Patients With Atrial Fibrillation , Circulation: Cardiovascular Quality and Outcomes, 10.1161/CIRCOUTCOMES.111.964023, 5, 3, (335-342), (2012).
  • Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative, Circulation, 10.1161/CIRCULATIONAHA.111.075929, 125, 14, (1748-1756), (2012).
  • Expression of oestrogen receptor β and prognosis of colorectal cancer, British Journal of Cancer, 10.1038/bjc.2012.323, 107, 5, (831-839), (2012).
  • Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention, The American Journal of Cardiology, 10.1016/j.amjcard.2012.08.008, 110, 12, (1756-1763), (2012).
  • Assessment of the value of a genetic risk score in improving the estimation of coronary risk, Atherosclerosis, 10.1016/j.atherosclerosis.2012.03.024, 222, 2, (456-463), (2012).
  • Mortality prediction in the elderly by an easily measured metabolic index, Diabetes and Vascular Disease Research, 10.1177/1479164111434317, 9, 3, (226-233), (2012).
  • Prediction of Incident Heart Failure in General Practice, Circulation: Heart Failure, 10.1161/CIRCHEARTFAILURE.111.964841, 5, 4, (422-429), (2012).
  • Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals, AIDS, 10.1097/QAD.0b013e328355d659, 26, 13, (1707-1717), (2012).
  • The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study, Atherosclerosis, 10.1016/j.atherosclerosis.2012.01.028, 222, 1, (135-137), (2012).
  • See more

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.